An Incorrect Biopharm Prediction, What’s Next?
There are past postings here about Achillion Pharmaceuticals, owned by Alexion Pharmaceuticals (ALXN) for around 12 months. Familiarity with the technology behind Achillion’s experimental drug Danicopan, now identified as ALXN2040… Read more »